Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
34.94 USD | -0.67% | +6.47% | +57.39% |
05-02 | Agios Pharmaceuticals Shares Rise After Reporting Smaller Q1 Loss | MT |
05-02 | Transcript : Agios Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 02, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.39% | 2B | |
+7.64% | 113B | |
+10.40% | 106B | |
+0.41% | 22.27B | |
-11.88% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.08% | 17.24B | |
+6.52% | 14.29B | |
+36.23% | 12.52B |
- Stock Market
- Equities
- AGIO Stock
- News Agios Pharmaceuticals, Inc.
- Canaccord Genuity Adjusts Agios Pharmaceuticals' Price Target to $44 from $52, Maintains Buy Rating